AZ-21 (Allozyne)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAZ-21 (Allozyne)
Drug Alias NamePEGylated FGF-21 (Allozyne)AZ-21 (Allozyne)
ClassificationBiologics
Mechanisms of ActionFibroblast growth factor receptors agonistsInsulin sensitizers
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllozyne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllozyne
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A